US20160264655A1
University of Texas System
CREB3L1 is a biomarker for identifying cancer cells sensitive to doxorubicin (daunomycin). The biomarker is used in diagnostics and screening; for example, to indicate suitability of doxorubicin chemotherapy and for pharmacological screens for agents that act through the same pathway